Swot Analysis of "ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk" written by Josh Lerner includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Immulogic Kirk facing as an external strategic factors. Some of the topics covered in ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk case study are - Strategic Management Strategies, Entrepreneurial management, Financial analysis, Financial management, Financial markets and Finance & Accounting.
Some of the macro environment factors that can be used to understand the ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk casestudy better are - – increasing government debt because of Covid-19 spendings, central banks are concerned over increasing inflation, supply chains are disrupted by pandemic , banking and financial system is disrupted by Bitcoin and other crypto currencies, digital marketing is dominated by two big players Facebook and Google, increasing energy prices, competitive advantages are harder to sustain because of technology dispersion,
increasing commodity prices, increasing inequality as vast percentage of new income is going to the top 1%, etc
Introduction to SWOT Analysis of ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk
SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Immulogic Kirk, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Immulogic Kirk operates in.
According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.
SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix
SWOT analysis of ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk can be done for the following purposes –
1. Strategic planning using facts provided in ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk case study
2. Improving business portfolio management of Immulogic Kirk
3. Assessing feasibility of the new initiative in Finance & Accounting field.
4. Making a Finance & Accounting topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Immulogic Kirk
Strengths ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The strengths of Immulogic Kirk in ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk Harvard Business Review case study are -
Training and development
– Immulogic Kirk has one of the best training and development program in the industry. The effectiveness of the training programs can be measured in ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk Harvard Business Review case study by analyzing – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.
Low bargaining power of suppliers
– Suppliers of Immulogic Kirk in the sector have low bargaining power. ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps Immulogic Kirk to manage not only supply disruptions but also source products at highly competitive prices.
Analytics focus
– Immulogic Kirk is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by Josh Lerner can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.
Digital Transformation in Finance & Accounting segment
- digital transformation varies from industry to industry. For Immulogic Kirk digital transformation journey comprises differing goals based on market maturity, customer technology acceptance, and organizational culture. Immulogic Kirk has successfully integrated the four key components of digital transformation – digital integration in processes, digital integration in marketing and customer relationship management, digital integration into the value chain, and using technology to explore new products and market opportunities.
Ability to lead change in Finance & Accounting field
– Immulogic Kirk is one of the leading players in its industry. Over the years it has not only transformed the business landscape in its segment but also across the whole industry. The ability to lead change has enabled Immulogic Kirk in – penetrating new markets, reaching out to new customers, and providing different value propositions to different customers in the international markets.
Successful track record of launching new products
– Immulogic Kirk has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Immulogic Kirk has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.
Innovation driven organization
– Immulogic Kirk is one of the most innovative firm in sector. Manager in ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk Harvard Business Review case study can use Clayton Christensen Disruptive Innovation strategies to further increase the scale of innovtions in the organization.
Ability to recruit top talent
– Immulogic Kirk is one of the leading recruiters in the industry. Managers in the ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk are in a position to attract the best talent available. The firm has a robust talent identification program that helps in identifying the brightest.
Sustainable margins compare to other players in Finance & Accounting industry
– ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk firm has clearly differentiated products in the market place. This has enabled Immulogic Kirk to fetch slight price premium compare to the competitors in the Finance & Accounting industry. The sustainable margins have also helped Immulogic Kirk to invest into research and development (R&D) and innovation.
Diverse revenue streams
– Immulogic Kirk is present in almost all the verticals within the industry. This has provided firm in ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk case study a diverse revenue stream that has helped it to survive disruptions such as global pandemic in Covid-19, financial disruption of 2008, and supply chain disruption of 2021.
High switching costs
– The high switching costs that Immulogic Kirk has built up over years in its products and services combo offer has resulted in high retention of customers, lower marketing costs, and greater ability of the firm to focus on its customers.
Superior customer experience
– The customer experience strategy of Immulogic Kirk in the segment is based on four key concepts – personalization, simplification of complex needs, prompt response, and continuous engagement.
Weaknesses ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The weaknesses of ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk are -
Slow decision making process
– As mentioned earlier in the report, Immulogic Kirk has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the industry over the last five years. Immulogic Kirk even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.
Compensation and incentives
– The revenue per employee as mentioned in the HBR case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk, is just above the industry average. Immulogic Kirk needs to redesign the compensation structure and incentives to increase the revenue per employees. Some of the steps that it can take are – hiring more specialists on project basis, etc.
Employees’ incomplete understanding of strategy
– From the instances in the HBR case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk, it seems that the employees of Immulogic Kirk don’t have comprehensive understanding of the firm’s strategy. This is reflected in number of promotional campaigns over the last few years that had mixed messaging and competing priorities. Some of the strategic activities and services promoted in the promotional campaigns were not consistent with the organization’s strategy.
High cash cycle compare to competitors
Immulogic Kirk has a high cash cycle compare to other players in the industry. It needs to shorten the cash cycle by 12% to be more competitive in the marketplace, reduce inventory costs, and be more profitable.
High operating costs
– Compare to the competitors, firm in the HBR case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk has high operating costs in the. This can be harder to sustain given the new emerging competition from nimble players who are using technology to attract Immulogic Kirk 's lucrative customers.
Ability to respond to the competition
– As the decision making is very deliberative, highlighted in the case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk, in the dynamic environment Immulogic Kirk has struggled to respond to the nimble upstart competition. Immulogic Kirk has reasonably good record with similar level competitors but it has struggled with new entrants taking away niches of its business.
Need for greater diversity
– Immulogic Kirk has taken concrete steps on diversity, equity, and inclusion. But the efforts so far has resulted in limited success. It needs to expand the recruitment and selection process to hire more people from the minorities and underprivileged background.
Skills based hiring
– The stress on hiring functional specialists at Immulogic Kirk has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.
High bargaining power of channel partners
– Because of the regulatory requirements, Josh Lerner suggests that, Immulogic Kirk is facing high bargaining power of the channel partners. So far it has not able to streamline the operations to reduce the bargaining power of the value chain partners in the industry.
Capital Spending Reduction
– Even during the low interest decade, Immulogic Kirk has not been able to do capital spending to the tune of the competition. This has resulted into fewer innovations and company facing stiff competition from both existing competitors and new entrants who are disrupting the industry using digital technology.
No frontier risks strategy
– After analyzing the HBR case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk, it seems that company is thinking about the frontier risks that can impact Finance & Accounting strategy. But it has very little resources allocation to manage the risks emerging from events such as natural disasters, climate change, melting of permafrost, tacking the rise of artificial intelligence, opportunities and threats emerging from commercialization of space etc.
Opportunities ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The opportunities highlighted in the Harvard Business Review case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk are -
Use of Bitcoin and other crypto currencies for transactions
– The popularity of Bitcoin and other crypto currencies as asset class and medium of transaction has opened new opportunities for Immulogic Kirk in the consumer business. Now Immulogic Kirk can target international markets with far fewer capital restrictions requirements than the existing system.
Lowering marketing communication costs
– 5G expansion will open new opportunities for Immulogic Kirk in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Finance & Accounting segment, and it will provide faster access to the consumers.
Developing new processes and practices
– Immulogic Kirk can develop new processes and procedures in Finance & Accounting industry using technology such as automation using artificial intelligence, real time transportation and products tracking, 3D modeling for concept development and new products pilot testing etc.
Increase in government spending
– As the United States and other governments are increasing social spending and infrastructure spending to build economies post Covid-19, Immulogic Kirk can use these opportunities to build new business models that can help the communities that Immulogic Kirk operates in. Secondly it can use opportunities from government spending in Finance & Accounting sector.
Building a culture of innovation
– managers at Immulogic Kirk can make experimentation a productive activity and build a culture of innovation using approaches such as – mining transaction data, A/B testing of websites and selling platforms, engaging potential customers over various needs, and building on small ideas in the Finance & Accounting segment.
Harnessing reconfiguration of the global supply chains
– As the trade war between US and China heats up in the coming years, Immulogic Kirk can build a diversified supply chain model across various countries in - South East Asia, India, and other parts of the world. This reconfiguration of global supply chain can help, as suggested in case study, ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk, to buy more products closer to the markets, and it can leverage its size and influence to get better deal from the local markets.
Creating value in data economy
– The success of analytics program of Immulogic Kirk has opened avenues for new revenue streams for the organization in the industry. This can help Immulogic Kirk to build a more holistic ecosystem as suggested in the ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk case study. Immulogic Kirk can build new products and services such as - data insight services, data privacy related products, data based consulting services, etc.
Remote work and new talent hiring opportunities
– The widespread usage of remote working technologies during Covid-19 has opened opportunities for Immulogic Kirk to expand its talent hiring zone. According to McKinsey Global Institute, 20% of the high end workforce in fields such as finance, information technology, can continously work from remote local post Covid-19. This presents a really great opportunity for Immulogic Kirk to hire the very best people irrespective of their geographical location.
Learning at scale
– Online learning technologies has now opened space for Immulogic Kirk to conduct training and development for its employees across the world. This will result in not only reducing the cost of training but also help employees in different part of the world to integrate with the headquarter work culture, ethos, and standards.
Manufacturing automation
– Immulogic Kirk can use the latest technology developments to improve its manufacturing and designing process in Finance & Accounting segment. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.
Leveraging digital technologies
– Immulogic Kirk can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.
Changes in consumer behavior post Covid-19
– Consumer behavior has changed in the Finance & Accounting industry because of Covid-19 restrictions. Some of this behavior will stay once things get back to normal. Immulogic Kirk can take advantage of these changes in consumer behavior to build a far more efficient business model. For example consumer regular ordering of products can reduce both last mile delivery costs and market penetration costs. Immulogic Kirk can further use this consumer data to build better customer loyalty, provide better products and service collection, and improve the value proposition in inflationary times.
Reconfiguring business model
– The expansion of digital payment system, the bringing down of international transactions costs using Bitcoin and other blockchain based currencies, etc can help Immulogic Kirk to reconfigure its entire business model. For example it can used blockchain based technologies to reduce piracy of its products in the big markets such as China. Secondly it can use the popularity of e-commerce in various developing markets to build a Direct to Customer business model rather than the current Channel Heavy distribution network.
Threats ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The threats mentioned in the HBR case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk are -
Regulatory challenges
– Immulogic Kirk needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the Finance & Accounting industry regulations.
Easy access to finance
– Easy access to finance in Finance & Accounting field will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Immulogic Kirk can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.
Aging population
– As the populations of most advanced economies are aging, it will lead to high social security costs, higher savings among population, and lower demand for goods and services in the economy. The household savings in US, France, UK, Germany, and Japan are growing faster than predicted because of uncertainty caused by pandemic.
Capital market disruption
– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Immulogic Kirk.
Environmental challenges
– Immulogic Kirk needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Immulogic Kirk can take advantage of this fund but it will also bring new competitors in the Finance & Accounting industry.
Backlash against dominant players
– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of Immulogic Kirk business can come under increasing regulations regarding data privacy, data security, etc.
Shortening product life cycle
– it is one of the major threat that Immulogic Kirk is facing in Finance & Accounting sector. It can lead to higher research and development costs, higher marketing expenses, lower customer loyalty, etc.
New competition
– After the dotcom bust of 2001, financial crisis of 2008-09, the business formation in US economy had declined. But in 2020 alone, there are more than 1.5 million new business applications in United States. This can lead to greater competition for Immulogic Kirk in the Finance & Accounting sector and impact the bottomline of the organization.
Increasing international competition and downward pressure on margins
– Apart from technology driven competitive advantage dilution, Immulogic Kirk can face downward pressure on margins from increasing competition from international players. The international players have stable revenue in their home market and can use those resources to penetrate prominent markets illustrated in HBR case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk .
Increasing wage structure of Immulogic Kirk
– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of Immulogic Kirk.
Barriers of entry lowering
– As technology is more democratized, the barriers to entry in the industry are lowering. It can presents Immulogic Kirk with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the sector.
High level of anxiety and lack of motivation
– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. Immulogic Kirk needs to understand the core reasons impacting the Finance & Accounting industry. This will help it in building a better workplace.
Learning curve for new practices
– As the technology based on artificial intelligence and machine learning platform is getting complex, as highlighted in case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk, Immulogic Kirk may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of Finance & Accounting .
Weighted SWOT Analysis of ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk Template, Example
Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants.
We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –
First stage for doing weighted SWOT analysis of the case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.
Second stage for conducting weighted SWOT analysis of the Harvard case study ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.
Third stage of constructing weighted SWOT analysis of ImmuLogic Pharmaceutical Corp. (B3): Katherine Kirk is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Immulogic Kirk needs to make to build a sustainable competitive advantage.